More is known about the structure and function of haemoglobin than practically any other protein.
Furthermore the rabbit and human reticulocyte systems have been used extensively for studies of haemoglobin synthesis and most of our present understanding of protein production in man has come from these sources. Thus a general outline of human haemoglobin synthesis offers a useful introduction, not only to the first section of this symposium which deals with haemoglobin specifically, but also to the discussions of other disorders resulting from abnormalities of structure or function of proteins, which follow. This brief review will highlight only a few areas of current interest in the field. For more extensive cover the reader is referred to several recent articles (Weatherall and Clegg, 1972; Huehns, 1974; Clegg, 1974;  Neinhuis and Anderson, 1974) .
The Human Haemoglobins
The normal human haemoglobins (Hbs) are summarized in table I. Each of them has a similar basic structure which consists of two distinct pairs of globin chains, each chain being associated with a haem group (see Huehns, 1974) . In adult life there is a major haemoglobin, Hb A (a2p2), and a minor fraction which makes up about 2-5% of the total, Hb A2 (a282). In intrauterine life the major haemoglobin is Hb F (a2y2). It has been shown recently that the Hb F is a mixture of molecular species with the formulae a2y2136glY and a2y2136ala (Schroeder (Schroeder and Huisman, 1970) . Before the eighth week of intrauterine life there are two embryonic haemoglobins called Hbs Gower 1 and 2. Hb Gower 2 has the formula a2e2 but the formula of Hb Gower 1 is uncertain. It has been shown recently that there is another intrauterine haemoglobin present in small amounts throughout fetal life which is called Hb Portland 1 and has the formula 42Y2. It is not certain whether the Hb Gower 1 has the molecular formula E4 or 62E2.
During fetal development there is an orderly switch from E to y chain production followed by fi and 8 chain production in adult life; a chain synthesis occurs throughout all stages of development but it is still not known whether a or E chains are the first products of the primitive mesenchyme. The haemoglobin changes during development have been reviewed recently (Weatherall, Pembrey, and Pritchard, 1974 ).
The Genetic Control of Human Haemoglobin Production
The genetic control of human haemoglobin is summarized in figure 1. There is good genetic evidence that the structure of each of the human adult globin chains and the y chains of Hb F is directed by one or more structural genes. Weatherall and Clegg, 1972; Huehns, 1974 The information which determines the structure of a globin chain is contained in the sequences of the base pairs which make up the DNA of the particular gene for that chain. The genetic code for proteins is a triplet code with three bases coding for each particular amino acid. It is degenerate in that there may be several triplets for any given amino acid. The information which is contained in the globin-chain gene has to be transferred into the cytoplasm to be translated into a peptide chain. This is achieved by the synthesis of a form of RNA called messenger RNA (mRNA) on the DNA template which forms the gene for that particular globin chain. Messenger RNA diffuses into the cell cytoplasm and acts as a template for protein synthesis. Since no RNA synthesis occurs after the orthochromatic normoblast stage all haemoglobin production in later normoblasts and reticulocytes must depend on the stability of preformed mRNA.
Since amino acids cannot interact directly with RNA they must be brought to the mRNA template on a series of carrier molecules. These are smallmolecular-weight RNA molecules called transfer RNAs (tRNAs). Each amino acid has one or more specific tRNAs which contain a triplet of bases, the anticodon, which can interact with complementary bases of the mRNA codons. The gowing peptide chains are held in place on the mRNA template by structures called ribosomes, each of which consists of two subunits.
Haemoglobin synthesis is carried out on groups of ribosomes strung along mRNA rather like a string of beads, called polysomes. There is still no definite evidence as to which chromosomes carry the human haemoglobin genes although they have been designated tentatively to chromosomes 2 and group B by DNA/RNA hybridization studies (Price, Conover, and Hirschhorn, 1972 (Huisman, Wrightstone, Wilson, Schroeder, and Kendall, 1972; Smith, Clegg, Weatherall, and Gilles, 1973) indicate that its non-a chains consist of the N-terminal residues of the y chain fused to the C-terminal residues of the ,8 chain. A tentative model for the production of this abnormal haemoglobin variant is shown in figure 2 (Nienhuis and Anderson, 1971; Benz and Forget, 1971) . More recently it has been possible to obtain milligram quantities of globin mRNA from rabbit reticulocytes and to obtain accurate molecular-weight estimations. The molecular weight of rabbit globin mRNA is estimated at about 220 000 + 10 000, and this exceeds by some 30 % the size required to code for 450 nucleotides, ie, to act as a template for a chain of 150 amino-acid residues long. A considerable part of this additional RNA consists of 50 to 75 bases of polyadenylic-acid(poly-A) residues near the 3' end, and indeed nearly all eukaryotic mRNAs seem to have such poly-A-rich regions. A further clue to the possible identity of the additional mRNA material has come from the studies of the human a-chain mutant Hb Constant Spring (Clegg, Weatherall, and Milner, 1971 ). This variant contains 31 additional residues at the C-terminal end of the a-chain and it has been suggested that it has arisen from a mutation of the chain-terminating codon UAA to UGA which codes for glutamine. Thus instead of stopping at residue 141 the message is read for a further 90 bases until another termination codon is reached, thus producing a chain with 31 extra amino-acid residues at the end. Further evidence that there are areas of mRNA at the 3' end of the a-chain mRNA which are not normally translated has come from studies of the frame-shift mutant Hb Wayne (Seid-Akhaven, Winter, and Rucknagel, 1972 There is now considerable evidence that mRNA is synthesized from a much larger precursor molecule which is present in all mammalian nuclei called heterogeneous nuclear RNA (Hn RNA) (Scherrer, Latham, and Darrell, 1963) . Thus it seems likely that genetic information is transferred first into the large nuclear precursor mRNA which contains the mRNA sequences at its 3' end. Most of this giant nuclear RNA is not transferred to the cytoplasm and presumably the smaller mRNA fraction is cleaved and diffuses into the cytoplasm to form a template for protein synthesis. The poly-A-rich sequences appear to be added after transcription from DNA.
So far little is known about the relative stabilities (Roberts, Clegg, Weatherall, and Ohta, 1973) .
The isolation of human mRNA has important applications to the study of a wide spectrum of pathological processes. For example, it has been possible to show that the thalassaemic defect can be reproduced in rabbit or other cell-free systems using 9S mRNA from /-thalassaemic reticulocytes. These findings suggest that the defect in haemoglobin production in thalassaemia is due to a reduced amount of mRNA for the particular chain involved (Neinhuis and Anderson, 1971; Benz and Forget, 1971) . It has been possible to obtain direct confirmation of this prediction by making highly radioactive DNA from rabbit or human a and : mRNA templates using a viral reverse transcriptase. The DNA produced in this way (cDNA) can then be used as a probe for hybridization experiments to measure the amounts of a and /3 mRNA in thalassaemia samples. This approach has shown a deficiency of mRNA for the a or / chain in a or / thalassaemia respectively (Kacian, Gambino, Dow, Grossbard, Natta, Ramirez, Speigelman, Marks and Bank. 1973; Housman, Forget, Skoultchi, and Benz, 1973) . Furthermore it should now be possible to use labelled cDNA produced on human mRNA templates to measure the number of gene copies for the a or /-chain loci, and this has important applications both in the determination of the number of copies normally present and for examining the possibility that some forms of thalassaemia or similar disorders result from specific gene deletions.'
Protein Synthesis in the Red Cell The three main steps in protein synthesis, namely, initiation, elongation, and termination, can each be discussed separately.
CHAIN 11NITIATION
Globin-chain initiation requires the basic ingredients of ribosomal subunits, mRNA, a specific met-tRNA, and several initiation factors. The initiation codon has been shown to be AUG and of the two major met-tRNA species in the red cell only one, mettRNAf, recognizes this codon; this is thus the initiating tRNA. In bacterial systems the methionine of this tRNA carries a formyl group but no such modified methionine residue has been demonstrated in eukaryotes. However it is customary to designate the initiator tRNA in mammals as tRNAf to distinguish it from the other met-tRNA, met-tRNAm, which inserts methionine into the peptide chain but is not involved in chain inhibition. It has been suggested that the sequence of events in initiation is as follows:
40S subunit + met tRNAf 40S/met tRNAf complex 40S met-tRNAf + mRNA 40S/met-tRNAf/mRNA complex 40S/met-tRNAf/mRNA + 60S -80S/met-tRNAf/mRNA complex. There are at least four protein initiation factors designated M1, M2a, M2b, and M3 (this nomenclature is confusing since it differs from that used by authors for bacterial initiation systems). The precise interaction of these factors in the initiation complex is not fully understood, nor is the action of haem which also seems to be involved in chain initiation. The initiation factors are required, together with GTP, for the binding of met-tRNAf to the 40S ribosomal subunit, and at least one factor, possibly M3, is required for the binding of mRNA to this complex. They are also required for the continued cyclization of ribosomes during protein synthesis (for a review see Crystal, Nienhuis, Pritchard, Picciano, Elson, Merrick, Graf, Shafritz, Laycock, Last, and Anderson, 1972) . Haem is required in the initiation process since it prevents the action of an inhibitor which interferes with the formation of the initiating met-tRNAf-40s complex (Legon, Jackson, and Hurst, 1973) . Experiments using 9S mRNA from different sources in heterologous cell-free systems have suggested that many of the initiation factors are common to several species. However there is evidence that there are at least some message-specific initiation factors. Furthermore, it appears that in some systems for mRNA, a and / chains are initiated with different degrees of efficiency, an important observation when such systems are used for the study of the defect in thalassaemia.
CHAIN ELONGATION
After the completion of the initiation complex the system is able to proceed with stepwise addition of the amino acids from the N-terminal end to form a growing peptide chain. This occurs in several distinct stages. The anticodon of the next amino acyl tRNA binds to the ribosomal site next to that occu-pied by the initiator or peptidyl tRNA. Peptide transfer then takes place between the newly bound amino-acyl tRNA and the met-tRNA. Finally the newly made peptidyl tRNA and mRNA are both shifted from the acceptor to the donor site on the ribosomes. In this way the acceptor site is freed and the process can be repeated by stepwise addition of amino acids, so resulting in elongation of the growing chain. At least two protein elongation factors have been implicated in this process, as well as the peptide-bond-forming enzyme peptidyl transferase.
Experiments in both rabbit and human reticulocytes have indicated that both a and fl-chain synthesis proceeds in a linear fashion at a uniform rate from N to C-terminal ends. The time for fl-chain translation in human cells is approximately 90 seconds at 37°C (Clegg, Weatherall, Na-Nakorn, and Wasi, 1968 (Clegg et al, 1971b) . Furthermore the findings in this variant and in the Hb Wayne frame-shift mutant (fig 3) , indicate that both UAA and UAG can act as terminators for human globin synthesis. In addition, in prokaryotes at least, termination requires the presence of at least two protein release factors, RI and RII, and polypeptidyl transferase. Little is known about the role of factors of this type in chain termination in higher organisms although at least one release factor appears to be necessary as well as GTP. The most likely sequence of events is that a polypeptidyl transferase catalyses the transfer of the peptidyl group of peptidyl tRNA to water rather than aminoacyl tRNA, in the presence of R factor. The peptide chain is thus released from the ribosomes and the tRNA which is left on the ribosome is then released by the action of another factor. The ribosomal subunits are available for further protein synthesis. Haem Synthesis and the Assembly of Haemoglobin The biosythesis of haem takes place in a series of enzyme-controlled steps (see Granick and Levere, 1964) beginning with the condensation of glycine and succinyl CoA to form a-amino-fl-keto-adipic acid which is then rapidly decarboxylated to form &-amino laevulinic acid (8ALA). This reaction, which is catalyzed by the enzyme ALA synthetase, and which requires pyridoxal phosphate and ferrous iron as cofactors, is the only step in the pathway which requires energy. All therest areessentiallyirreversible. Two molecules of ALA combine to form porphobilinogen under the action of ALA dehydrase and then four of the porphobilinogen molecules combine to form the basic tetrapyrrole ring, uroporphyrinogen. After various modifications this is converted to protoporphyrinogen which is oxidized to protoporphyrin. Iron is then inserted by the enzyme haem synthetase to form haem. The first and last steps on the pathway are mitochondrial while the rest occur in the cell cytoplasm.
The precise details of the assembly of the finished haemoglobin tetramer have yet to be worked out (see Huehns, 1974) . Evidence from both rabbit and human reticulocyte experiments suggests that there is a slight degree of chain imbalance in normal cells with the formation of a small pool of a chains. It seems likely that the al3 dimer is an intermediate in haemoglobin synthesis and the likely sequence of events is that af globin combines with haem and then immediately combines with a like subunit to form the stable tetramer. It is not certain whether haem combines with globin while still on the ribosomes although this seems likely since it is probable that the chain assumes its complicated folded configuration as it is assembled and that haem fits into the haem pocket during this process.
The Regulation of Haemoglobin Synthesis
Although there is now general agreement about the main steps involved in the synthesis of haemoglobin very little is known about how this process is controlled. The erythrocyte is a highly specialized cell
Step No. Synthesis Procedure (table II) . DNA and RNA synthesis must be geared to the various stages of erythroid-precursor maturation. Control mechanisms must be involved in the turning off of these genes and in activating the haemoglobin genes half way through maturation. During the later steps of maturation protein synthesis is almost totally directed towards the production of haemoglobin and all other genes must be repressed. During this time, in adult life, haemoglobins A and A2 are being produced at markedly different rates and clearly some form of control must maintain this ratio at a constant level. All the other areas of DNA in the red cell precursors, which are not involved in the production of red-cell proteins, must be suppressed throughout maturation.
Some form of control mechanism must be involved in the orderly changeover of globin chains which occurs during differentiation, ie, the switch between embryonic, fetal, and adult globin chains. Throughout maturation there is fairly good coordination between a and non-a-chain production, and, since the genes controlling the a and ,8 chains are at some distance apart, some form of coordinating system must be invoked to maintain these gene products at roughly equal levels. Similarly, since there is no evidence for a large excess of haem or globin at any stage of maturation, mechanisms must exist which coordinate these completely different metabolic pathways to produce similar amounts of end product. Finally some form of relatively crude control is required to stop haemoglobin synthesis when the cellular haemoglobin content reaches a critical level.
Quite clearly control of protein synthesis in the red cell can occur either at gene level, ie, such processes as gene duplication or amplification; at transcriptional level, ie, the rate of RNA production; or during the posttranscriptional processes of RNA processing, transport, or stability and the rate of chain initiation, elongation, and termination ( (Paul, 1972; Neinhuis and Anderson, 1974) . The bacterial chromosome exists in the cytoplasm as metabolically active DNA with only small amounts of basic protein, but in eukaryotes the DNA is associated with The Hn RNA is synthesized by an enzyme RNA polymerase and the repeating adenine bases (A) are added at the 3' end. Before transportation to the cytoplasm a large portion at the 5' end of the Hn RNA is cleaved and the functional mRNA is transported by an unknown mechanism into the cytoplasm, where it acts as a template for protein synthesis. large amounts of protein and is restricted in its ability to direct RNA synthesis. Two classes of protein have been found in chromatin, the histones and non-histone acidic proteins. The observation that there has been conservation of amino-acid composition of histones during evolution, and the fact that there are limited numbers present in various tissues, has suggested that these molecules are an integral part of chromatin, and impose non-specific restriction on gene expression. It seems unlikely that they have the unique properties necessary for controlling expression in differentiated cells. There are certain exceptions to this observation, however, and a unique histone has been found in immature chick red-cell precursors, which increases in amount during maturation, suggesting that it has a role in the condensation of the cell nucleus. The acidic proteins on the other hand are a highly heterogeneous group which includes many of the enzymes involved in DNA and RNA metabolism. They turn over rapidly and it is possible that some of them may represent specific repressor proteins. It has been shown recently that globin-mRNA sequences can be transcribed from erythroid chromatin using RNA polymerase from E. coli. Gilmour (1973) has been able to transfer the ability to direct the transcription of the globin mRNA sequence to brain chromatin using the acidic protein fraction from mouse embryonic liver erythroblasts. These experiments suggest that these molecules may play a key role in the control of structural gene transcription.
It has been shown that only a small fraction of eukaryotic DNA is required for directing the structure of protein and there is a mass of DNA which has no obvious function. Much of this consists of repetitive sequences and it has been suggested that the repetitious DNA plays a regulatory role in the control of protein synthesis in higher organisms. Based on these observations Crick, Britten, Davidson, and others have evolved models involving the interaction of various batteries of control genes which are designed to explain such complex activities as differentiation in higher organisms (Britten and Davidson, 1969; Crick, 1971) . The most fully worked out model is that of Britten and Davidson (1969) . In brief their model requires the interaction of various sensor and activator RNAs. A sensor DNA locus is able to recognize specific inducer molecules (hormones for example) and initiates transcription on an adjacent integrator gene after receipt of an appropriate stimulus. An activator RNA is produced at the integrator-gene loci and complexes with DNA at a distant receptor gene allowing transcription of a series of producer genes coding for several proteins with interrelated metabolic functions. This system would explain, for example, how hormones may produce a variety of gene products and would form a basis for the complex processes of multitissue differentiation. It is relatively easy to apply this model to systems such as red-cell differentiation where there are many genes involved in the production of haemoglobins, enzymes, membrane proteins, etc, at different stages of development. One of the requirements of this model is the existence of a class of nuclear RNA located in chromatin and bound to DNA in a sequence-specific manner. Mayfield and Bonner (1972) have provided evidence that such a class exists. Thus after partial hepatectomy they found that the first response was the synthesis of a rapidly labelled high-molecular-weight RNA with novel sequences. This event was followed by increased amounts of chromosomal or low molecular weight RNA, again with sequences not usually produced by liver. Subsequently mRNA synthesis for liver protein increased before initiation of DNA synthesis occurred. This sequence of events is exactly as predicted by Britten and Davidson (1969 Stent (1964) and Elston and Glassman (1967) and they feel that current evidence for a eukaryote system suggests a lack of negative control.
Despite these observations, however, there is increasing evidence that there are areas of the chromosomes carrying the y, /, and &-chain genes which are involved in the neonatal suppression or activation of the y and fl-chain genes. Thus where areas of the Ay, 8, and /3 genes have been deleted in the production of Hb Kenya, there is persistent activity of the remaining Gy locus (Huisman et al, 1972; Smith et al, 1973) . This suggests that areas of DNA have been removed in the deletion which are involved normally in the neonatal suppression of this locus. A similar argument can be used to explain the findings in many forms of hereditary persistence of haemoglobin F in man (Huisman, Schroeder, Efremov, Duma, MIadenovski, Hyman, Rachmilewitz, Bouver, Miller, Brodie, Shelton, Shelton, and Apell, 1974 (Hunter and Jackson, 1972) .
The relative number of ribosomes making a and ,8 chains are approximately equal while the average size of the a-chain polysomes is somewhat smaller than those making ,B chains. This would indicate that there is slightly more a-chain mRNA being utilized than ,B mRNA. This situation occurs in both rabbit and human reticulocytes (Hunt, Hunter, and Munro, 1968; Clegg, Weatherall, and Eunson, 1971) and further studies by Lodish and Jacobson (1972) have shown that the difference in polysome sizes is due entirely to the faster rate of initiation of/3 chains. All these experiments suggest that there is a slight excess of a mRNA which leads to an overproduction of a chains in the order of 10 to 20 %; presumably most of these excess chains are destroyed by proteolysis.
Studies of the relative rates of a and /3 chain synthesis in different cell-free systems suggests that there may be some form of positive control of the initiation rates for a and /3 chains since there seems to be a marked difference in the relative rates of initiation between heterologous systems. Furthermore haem seems to be involved in the control of initiation, probably by interacting with a specific inhibitor of protein synthesis. There is some evidence that haem deficiency affects a chain synthesis more than that of /3 chains.
As mentioned earlier, there is a slight excess of a chains in human red cell precursors. After association of a and / chains to produce an af dimer the stable tetramer forms rapidly. It is possible that some control occurs at this level due to unequal affinity of various haemoglobin subunits for each other. Thus, for example, when there is a deficiency of a chains as in a thalassaemia, Hb A seems to be produced at the expense of mutant / chain variants such as Hbs S or E. How much differential subunit affinity can account for the levels of different haemoglobins during development is uncertain, but this seems unlikely to be an important control mechanism in normal haemoglobin production.
The Control of Haemoglobin Production during Maturation
If knowledge about the control mechanisms of normal adult haemoglobin production is scanty, there is virtually no information whatever as to how the normal processes of switching from embryonic to fetal and fetal to adult haemoglobin production are controlled during maturation. This problem has been the subject of several recent reviews (Lorkin, 1972; Weatherall et al, 1974) .
It is now well established that the fetal-to-adult- Recent studies by Wood and Weatherall (1973) have shown that the switch from Hb F to Hb A is completely synchronous throughout all sites of fetal erythropoiesis. The type of control required to achieve this remarkable degree of synchronization could be based on the models suggested by Britten and Davidson as suggested in an earlier section. Since the level of Hb F rises in some normal women during pregnancy (Pembrey, Weatherall, and Clegg, 1973) , it is tempting to invoke some form of hormonal control for the switch mechanism but the nature of this is completely obscure. As already mentioned there is strong evidence that areas of DNA of the human haemoglobin-gene complex exist which are involved specifically in the repression of y chain production in adult life; when these are deleted the normal neonatal suppression of y chain synthesis fails. Thus we have a series of tantalizing clues to the general nature of the Hb F to Hb A switch but no idea whatever of the precise mechanisms involved. One of the major difficulties in understanding the switch mechanisms is the observation that in most conditions in which Hb F production continues into adult life it is heterogeneously distributed within the red cells. Indeed it is only in some forms of hereditary persistence of fetal haemoglobin that the Hb F is uniformly distributed, The heterogeneity of Hb F synthesis is difficult to ascribe to a primary genetic mechanism and obviously there must be local tissue factors involved in fixing the final level of Hb F and Hb A in specific precursor cell lines. The cause of this phenomenon is completely obscure.
Sununary
The major steps in haemoglobin synthesis in red cell precursors are now worked out and only details of specific mechanisms remain to be filled in. Thus the major steps in the production of a globin chain are the transcription of large-molecular-weight precursor mRNA (Hn RNA) from the appropriate gene, the cleavage of Hn RNA to produce definitive template mRNA which diffuses into the cell cytoplasm, the processes of chain initiation, translation, and termination, and finally the association of subunits to form a stable tetramer. From what little information there is it appears that this complex series of events is controlled at several levels but that the major control mechanisms are mediated in the processes of D. J. Weatherall transcription rather than translation. There is increasing evidence that the chromatin proteins, particularly the acidic proteins, have specific functions in maintaining areas of DNA repressed and that activation of the haemoglobin loci results from complex interactions with external inducers, the nature of which is not yet known. Virtually nothing is known about the factors involved in the switch from the intrauterine to adult haemoglobins although this appears to be a coordinated event throughout the erythropoietic tissue of the fetus.
The isolation and characterization of human mRNA has made possible both the study of the function of thalassaemic mRNA in heterologous systems and, more recently, its quantitation in abnormal red-cell precursors. Furthermore the ability to make cDNA using viral reverse transcriptase has made possible the estimation of the number of haemoglobin genes, both in normal human subjects and in those with different forms of thalassaemia and other genetic disorders of haemoglobin production.
